Abstract
Clinical Pharmacology & TherapeuticsVolume 81, Issue 4 p. 477-479 Macroscopy Future of Pediatric Therapeutics: Reauthorization of BPCA and PREA Correction(s) for this article Future of Pediatric Therapeutics: Reauthorization of BPCA and PREA R M Ward, R Kauffman, Volume 81Issue 6Clinical Pharmacology & Therapeutics pages: 910-910 First Published online: April 11, 2007 R M Ward, Corresponding Author R M Ward [email protected] Pediatric Pharmacology Program, University of Utah, Salt Lake City, Utah, USASearch for more papers by this authorR Kauffman, R Kauffman Medical Research Department, Children's Mercy Hospital, University of Missouri, Kansas City, Missouri, USASearch for more papers by this author R M Ward, Corresponding Author R M Ward [email protected] Pediatric Pharmacology Program, University of Utah, Salt Lake City, Utah, USASearch for more papers by this authorR Kauffman, R Kauffman Medical Research Department, Children's Mercy Hospital, University of Missouri, Kansas City, Missouri, USASearch for more papers by this author First published: 21 February 2007 https://doi.org/10.1038/sj.clpt.6100109Citations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume81, Issue4Maternal and Child HealthApril 2007Pages 477-479 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.